Nu Skin Enterprises Q1 2025 10-Q Filed
Ticker: NUS · Form: 10-Q · Filed: 2025-05-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, debt-repayment, financial-reporting
TL;DR
**NU SKIN Q1 2025 10-Q FILED: DEBT PAYMENTS ON TRACK OVER 5-YEAR TERM STARTING SEPT 2022.**
AI Summary
Nu Skin Enterprises, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. A significant note mentions that 21% of a principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder due at the end of the term.
Why It Matters
This filing provides investors with the latest financial snapshot of Nu Skin Enterprises, including details on its debt obligations and their repayment schedule.
Risk Assessment
Risk Level: medium — The filing details a multi-year debt repayment schedule, which carries inherent financial risks and obligations for the company.
Key Numbers
- 21% — Installment Payment Percentage (Percentage of principal amount payable in increasing quarterly installments over five years.)
- 5-year — Payment Term (Duration of the installment payment period for a portion of the principal.)
Key Players & Entities
- NU SKIN ENTERPRISES, INC. (company) — Filer of the 10-Q
- September 30, 2022 (date) — Start date of the five-year installment payment period
- 21% (dollar_amount) — Portion of principal amount payable in installments
FAQ
What is the total principal amount subject to the five-year installment payment plan?
The filing states that 21% of the principal amount is payable in installments, but the total principal amount is not specified in the provided text.
When did the five-year installment payment period begin?
The five-year installment payment period began on September 30, 2022.
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending March 31, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 5122, for Wholesale - Drugs, Proprietaries & Druggists' Sundries.
Who is listed as the primary contact for business correspondence?
Gregory Belliston is listed as the contact for business and mail address.
From the Filing
0001140361-25-018024.txt : 20250509 0001140361-25-018024.hdr.sgml : 20250509 20250508205203 ACCESSION NUMBER: 0001140361-25-018024 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250509 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services EIN: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 25928101 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 10-Q 1 ef20047667_10q.htm 10-Q false 12-31 2025 Q1 0001021561 member of our Board of Directors member of our Board of Directors P101D P101D 4532 4532 Variable 30 day: 6.67% 21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term. 2025-02 2025-05 0001021561 2025-01-01 2025-03-31 0001021561 2025-04-30 0001021561 2025-03-31 0001021561 2024-12-31 0001021561 2024-01-01 2024-03-31 0001021561 us-gaap:RetainedEarningsMember 2024-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2023-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-12-31 0001021561 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001021561 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001021561 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001021561 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001021561 us-gaap:TreasuryStockCommonMember 2025-03-31 0001021561 us-gaap:RetainedEarningsMember 2024-03-31 0001021561 2024-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001021561 us-gaap:RetainedEarningsMember 2025-03-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-03-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-03-31 0001021561 nus:EdwinaWoodburyMember 2025-01-01 2025-03-31 0001021561 nus:EmmaBattleMember 2025-01-01 2025-03-31 0001021561 nus:EdwinaWoodburyMember 2025-03-31 0001021561 nus:EmmaBattleMember 2025-03-31 0001021561 nus:RestructuringPlan2023Member 2025-01-01 2025-03-31 0001021561 nus:MyFavoriteThingsIncMember 2025-01-02